About: BCAL Diagnostics Limited, a biotechnology company, engages in developing a novel blood screening test to support the early diagnosis and monitoring of breast cancer in Australia. It is involved in the development and commercialization of BREASTESTplus; Avantect Pancreatic; Avantect Ovarian; BREASTESTplus 2; BREASTEST Monitor; and Avantect multi-cancer test. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: A$0.09 (+1.11%)
BDX ASX Bcal Diagnostics Ltd
Bcal Diagnostics Ltd share price
BDX price activity
Last Price
$0.090
Change (24hr)
0.00 AUD (1.11%)
Volume
10.37K
Volume (4w avg)
-
Open
$0.09
Day Range
$0.09 - $0.09
Previous Close
$0.09
Last Trade
11 Oct, 11:13 pm GMT+0
Delayed
11 Oct, 11:13 pm GMT+0
BDX price performance
Delayed
11 Oct, 11:13 pm GMT+0
BDX Market Signals